This message was sent to ##Email##
|
|
|
|
|
| |
| HEALTH CARE NEWS AND UPDATES |
USA Today
Early research by Danish scientists suggests artificial ovaries might one day be available to young cancer patients unable to naturally conceive.
A paper presented recently at the annual meeting of the European Society of Human Reproduction and Embryology shows how scientists are creating the framework for artificial ovaries.
READ MORE
Futurity
New research links higher body fat with lower breast cancer risk before menopause.
While obesity has been shown to increase breast cancer risk in postmenopausal women, the large-scale study found that the opposite was true for premenopausal women.
READ MORE
 |
|
Our ihcDirect® method yields a revolutionary technology that opens a spectrum of new clinical applications including intraoperative surgery. Using the Novodiax PolyHRP technology, Intraoperative IHC tests can now be completed in just 10 minutes using fresh frozen tissues.
For more details, see our
 ihcDirect® product list.
|
|
News-Medical.Net
New methods of studying the evolution of treatment resistance in head and neck cancer are being developed by researchers at the Johns Hopkins Kimmel Cancer Center.
The scientists wanted to examine how cancers acquire resistance to treatment over time and whether those changes could be modeled computationally to determine patient-specific timelines of resistance.
READ MORE
Cancer Research UK
Scientists have discovered that cancerous cells in an aggressive type of childhood brain tumor work together to infiltrate the brain, and this finding could ultimately lead to much needed new treatments, according to a new study published in Nature Medicine. In the study, funded by Cancer Research UK with support from Abbie’s Army and the DIPG Collaborative, the researchers investigated a type of childhood brain tumor called diffuse intrinsic pontine glioma, shining a light on its most aggressive characteristic — its ability to leave the brain stem and send cancer cells to invade the rest of the brain.
READ MORE
|
Promoted by
|
|
|
|
 |
Georgia State University
An amino acid transporter named xCT may affect the growth and progression of non-small cell lung cancer, a discovery that may predict the five-year survival rate of patients suffering from this cancer, now at 16 percent, researchers at Georgia State University and Vanderbilt University Medical Center have concluded.
The team, led by Xiangming Ji of Georgia State and Pierre Massion of Vanderbilt University Medical Center, published their findings in the current issue of Oncogene.
READ MORE
The Blade
Breast cancer has been one of the hottest fields of scientific research for more than 50 years now, with widely recognized public campaigns to increase awareness and education. These combined efforts have led to much improved survival outcomes during this time. The five-year survival for earliest stages is close to 100 percent, 93 percent for the second earliest stage 2, and 72 percent for stage 3.
READ MORE
|
Promoted by
|
|
|
|
 |
Express
Testicular cancer is quite uncommon, but it’s important to recognize all the signs. It’s one of the most treatable of all cancers, and most men make a full recovery, particularly if the cancer is diagnosed early. So what is the biggest indicator of the disease?
READ MORE
| ACS CANCER PROGRAMS UPDATES |
ACS
Please join the American Joint Committee on Cancer for a free webinar on Head and Neck Staging for the 8th Edition Cancer Staging Manual. The webinar will be held at 1 p.m. EDT July 25. Donna Gress, RHIT, CTR, will facilitate the webinar. In this webinar you will learn how to:
- Explain cervical nodes and unknown primary tumors
- Examine importance of EBV and HPV-mediated (p16+)
- Analyze extranodal extension (ENE)
Register here.
 |
|
Donate now to help Doctors Without Borders bring emergency medical care where it is needed most. Doctors Without Borders USA relies on unrestricted donations from private donors so when an emergency strikes we assess the needs and can act fast.
Donate today.
|
|
ACS
The American College of Surgeons (ACS) 2018 Cancer Programs Annual Conference: Learn. Interact. Transform provides cutting-edge solutions to help you deliver high-quality, patient-centered, multidisciplinary care to patients with cancer. Through a combination of plenaries, breakout sessions and networking opportunities you will leave this conference reinvigorated and ready to overcome the challenges facing you as a cancer care provider.
Conference Highlights:
- CoC Accreditation 101 and Pursing Excellence though NAPBC Accreditation Pre-Conference Workshops on Wednesday, Sept 5
- Value of Navigation and Survivorship
- Mock Tumor Boards
- Components of a Quality Study
- Poster Sessions (we are still accepting applications – submit poster submission today)
- Exhibits
Detailed information, as well as conference agenda, can be found on the Cancer Programs Annual Conference website.
Register now to take advantage of the early bird registration fee and SAVE.
READ MORE
American College of Surgeons - NAPRC
The National Accreditation Program for Rectal Cancer (NAPRC) is now accepting applications. The NAPRC was developed to ensure that rectal cancer patients receive appropriate care following a multidisciplinary approach. Programs will be evaluated on the standards and metrics outlined in The National Accreditation Program for Rectal Cancer Standards Manual 2017 (revised October 2017).
READ MORE
ACS
The AJCC Cancer Staging Manual is the gold standard to help the cancer patient management team determine the correct stage for patients, allowing for the most appropriate care plan.
The AJCC Cancer Staging Manual is used by physicians and health care professionals throughout the world to facilitate the uniform description and reporting of neo-plastic diseases. Proper classification and staging of cancer is essential for the physician to assign proper treatment, evaluate results of management and clinical trials and to serve as the standard for local, regional and international reporting on cancer incidence and outcome.
This corrected third printing includes the following features:
- Revised breast cancer staging system
- Revised histology codes in each chapter
- Corrected errata posted on www.cancerstaging.org through Feb. 2, 2018
Special 25 percent discount expires Sept. 30!
Order your copy today.
ACS
The National Cancer Database (NCDB) is pleased to announce that the Participant User File (PUF) application will open July 9 through Aug. 6. The NCDB will accept applications for site-specific files, which include cases diagnosed between 2004 and 2015. The 2016 PUF, which will include 2004-2016 diagnosis years, will be available for request during the next application period, January 2019.
The NCDB PUF is a Health Insurance Portability and Accountability Act (HIPAA) compliant data file containing cases submitted to the Commission on Cancer's (CoC) NCDB and complies with the terms of the Business Associate Agreement between the American College of Surgeons and cancer programs accredited by the CoC; i.e., no patients or facilities can be identified. The PUF is designed to provide investigators at CoC-accredited cancer programs with a data resource they can use to review and advance the quality of care delivered to cancer patients through analyses of cases reported to the NCDB.
For more information, review the PUF Website.
Questions regarding the NCDB PUFs or the RFA process for a PUF may be directed to NCDB technical staff at NCDB_PUF@facs.org.
| IMPORTANT DATES AND DEADLINES |
| Date |
Event |
Location |
| July 21-24 |
ACS Quality and Safety Conference
|
Orlando, FL
|
| Sept. 5-7 |
2018 Cancer Programs Conference
|
Chicago, IL
|
| Oct. 21-25 |
ACS Clinical Congress
|
Boston, MA
|
|
Missed last week's issue? See which articles your colleagues read most.
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
The Brief
Connect with AJCC
Connect with CoC
Connect with NAPBC
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Cancer Programs do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the authors and not of the American College of Surgeons, and the Cancer Programs.
American College of Surgeons
633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
